May 23, 2007 - EDAP TMS S.A., a developer of High Intensity Focused Ultrasound (HIFU) treatments of prostate cancer recently announced it is fast-tracking its ongoing U.S. Ablatherm-HIFU clinical trial due to results presented at the European Association of Urologists (EAU) in March, 2007.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now